Stonebridge Capital Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100
Closed -$3.42K 889
2023
Q3
$3.42K Hold
100
﹤0.01% 751
2023
Q2
$4K Hold
100
﹤0.01% 742
2023
Q1
$3.93K Hold
100
﹤0.01% 741
2022
Q4
$3.18K Hold
100
﹤0.01% 751
2022
Q3
$3K Hold
100
﹤0.01% 774
2022
Q2
$4K Hold
100
﹤0.01% 749
2022
Q1
$5K Hold
100
﹤0.01% 788
2021
Q4
$6K Hold
100
﹤0.01% 720
2021
Q3
$6K Sell
100
-100
-50% -$6.16K ﹤0.01% 707
2021
Q2
$12K Buy
200
+100
+100% +$6.59K ﹤0.01% 722
2021
Q1
$6K Buy
+100
New +$5.8K ﹤0.01% 720
2020
Q3
Sell
-100
Closed -$4K 735
2020
Q2
$4K Hold
100
﹤0.01% 604
2020
Q1
$4K Hold
100
﹤0.01% 590
2019
Q4
$6K Hold
100
﹤0.01% 633
2019
Q3
$5K Hold
100
﹤0.01% 632
2019
Q2
$6K Buy
+100
New +$5.37K ﹤0.01% 654

Other funds holding XRAY

Stonebridge Capital Advisors's XRAY Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Dentsply Sirona (XRAY) in Q4 2023, closing a stake of 100 shares — an estimated $3.42K sold.

Stonebridge Capital Advisors first reported a position in XRAY in Q2 2019 and held it in 16 quarters. The position peaked at $12K in Q2 2021. 416 funds tracked by Wall St. Rank hold XRAY as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Dentsply Sirona position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 100 Dentsply Sirona shares in Q4 2023, an estimated $3.42K.
  • Stonebridge Capital Advisors first reported a position in Dentsply Sirona in Q2 2019 and held it in 16 quarters.
  • Stonebridge Capital Advisors's Dentsply Sirona position peaked at $12K in Q2 2021.
  • 416 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.